Cargando…

Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells

Mast cells are tissue-resident cells that contribute to allergic diseases, among others, due to excessive or inappropriate cellular activation and degranulation. Therapeutic approaches to modulate mast cell activation are urgently needed. Siglec-6 is an immunoreceptor tyrosine-based inhibitory motif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robida, Piper A., Rische, Clayton H., Morgenstern, Netali Ben-Baruch, Janarthanam, Rethavathi, Cao, Yun, Krier-Burris, Rebecca A., Korver, Wouter, Xu, Alan, Luu, Thuy, Schanin, Julia, Leung, John, Rothenberg, Marc E., Wechsler, Joshua B., Youngblood, Bradford A., Bochner, Bruce S., O’Sullivan, Jeremy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997871/ https://www.ncbi.nlm.nih.gov/pubmed/35406705 http://dx.doi.org/10.3390/cells11071138

Ejemplares similares

Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells
por: Schanin, Julia, et al.
Publicado: (2022)

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
por: Gebremeskel, Simon, et al.
Publicado: (2021)

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation
por: Korver, Wouter, et al.
Publicado: (2022)

Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells
por: Cao, Yun, et al.
Publicado: (2023)

Discovery, Function, and Therapeutic Targeting of Siglec-8
por: Youngblood, Bradford A., et al.
Publicado: (2020)

Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice
por: Wei, Yadong, et al.
Publicado: (2018)

A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
por: Schanin, Julia, et al.
Publicado: (2020)

Bioactive multi-protein adsorption enables targeted mast cell nanotherapy
por: Du, Fanfan, et al.
Publicado: (2023)

Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
por: Park, Chang-Shin, et al.
Publicado: (2011)

Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins
por: O’Sullivan, Jeremy A., et al.
Publicado: (2017)

Mast cell activation is associated with post‐acute COVID‐19 syndrome
por: Wechsler, Joshua B., et al.
Publicado: (2021)

Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death In Vitro
por: Carroll, Daniela J., et al.
Publicado: (2021)

Predicting mortality in critically ill patients with diabetes using machine learning and clinical notes
por: Ye, Jiancheng, et al.
Publicado: (2020)

Identification of a Siglec-F+ granulocyte-macrophage progenitor
por: Bolden, Jessica E., et al.
Publicado: (2018)

Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells
por: Yu, Yingxin, et al.
Publicado: (2018)

Bidirectional Crosstalk Between Eosinophils and Esophageal Epithelial Cells Regulates Inflammatory and Remodeling Processes
por: Dunn, Julia L. M., et al.
Publicado: (2021)

The mast cell/S1P axis is not linked to pre-lesional male skin remodeling in a mouse model of eczema
por: Tanis, Ross M., et al.
Publicado: (2021)

Skin Mast Cell-Driven Ceramides Drive Early Apoptosis in Pre-Symptomatic Eczema in Mice
por: Robida, Piper A., et al.
Publicado: (2021)

Single-cell RNA-Seq of human esophageal epithelium in homeostasis and allergic inflammation
por: Rochman, Mark, et al.
Publicado: (2022)

Anti-Bacterial and Anti-Fungal Activity of Xanthones Obtained via Semi-Synthetic Modification of α-Mangostin from Garcinia mangostana
por: Narasimhan, Srinivasan, et al.
Publicado: (2017)

Allergic inflammation is initiated by IL-33–dependent crosstalk between mast cells and basophils
por: Hsu, Chia-Lin, et al.
Publicado: (2020)

New Insights into the Mechanism of the Down-Regulation of Mast Cells in the Treatment of Interstitial Cystitis: Possible Role of Siglecs
por: Lee, Tack
Publicado: (2011)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development
por: Baruch-Morgenstern, Netali Ben, et al.
Publicado: (2013)

Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169)
por: Bradford, Barry M, et al.
Publicado: (2014)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Mechanisms of Siglec-F-Induced Eosinophil Apoptosis: A Role for Caspases but Not for SHP-1, Src Kinases, NADPH Oxidase or Reactive Oxygen
por: Mao, Hui, et al.
Publicado: (2013)

Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2018)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Resveratrol Protects against Skin Inflammation through Inhibition of Mast Cell, Sphingosine Kinase-1, Stat3 and NF-κB p65 Signaling Activation in Mice
por: Carlucci, Christopher D., et al.
Publicado: (2023)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Siglecs at the Host–Pathogen Interface
por: Chang, Yung-Chi, et al.
Publicado: (2020)

Siglecs as Therapeutic Targets in Cancer
por: Lim, Jackwee, et al.
Publicado: (2021)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
por: Chan, Chilam, et al.
Publicado: (2023)

Siglecs in Brain Function and Neurological Disorders
por: Siddiqui, Shoib Sarwar, et al.
Publicado: (2019)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14
por: Murch, Simon H.
Publicado: (2020)

The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
por: Smith, Benjamin A. H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c6b3793jevrun7kssevhjr0b6c